| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
966 |
859 |
$525K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
417 |
377 |
$233K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,625 |
2,375 |
$120K |
| 92134 |
|
2,550 |
2,454 |
$27K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
107 |
104 |
$27K |
| 92226 |
|
433 |
412 |
$4K |
| J9035 |
Injection, bevacizumab, 10 mg |
91 |
82 |
$3K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
101 |
100 |
$1K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
12 |
12 |
$378.57 |
| 92201 |
|
58 |
56 |
$264.31 |